ARS Pharma’s epinephrine nasal spray 1mg now available in US

GlobalData

Thu, May 8, 2025, 2:06 AM 2 min read

ARS Pharmaceuticals has announced the availability of neffy (epinephrine nasal spray) 1mg successful the US, providing a caller enactment for treating Type I allergic reactions, including anaphylaxis, successful children weighing betwixt 15 and 30kg.

Approved by the US Food and Drug Administration (FDA) successful March 2025, the spray is present accessible connected medicine successful a compact and user-friendly format intended arsenic a convenient summation to a lunchbox oregon backpack.

Human origin studies person demonstrated that users could instrumentality neffy by pursuing the instructions. 35% mistake rates person been observed with injectable epinephrine devices.

The spray has a support beingness of 2 years and tin withstand somesthesia exposures up to 122°F (50°C) for up to 3 months.

Even if frozen unintentionally, the product's reliability and prime stay unaffected aft thawing.

ARS Pharmaceuticals main commercialized serviceman Eric Karas stated: “The availability of the 1mg dose earlier summertime travel, camps and back-to-school play volition assistance communities amended hole for allergic emergencies.

“The needle-free plan of neffy besides eliminates the hazard of adverse events, specified arsenic accidental injections into the hands oregon fingers of a kid oregon caregiver, which happens astir 3,500 times each year. Now is simply a large clip for parents to scope retired to their healthcare providers to inquire for neffy arsenic a attraction for their young children.”

In the European Union (EU), wherever the spray is marketed arsenic EURneffy, it is indicated for exigency attraction of allergic reactions owed to allergens, and for idiopathic oregon exercise-induced anaphylaxis successful big and paediatric patients weighing 30 kgs oregon more.

Type I allergic reactions tin beryllium life-threatening, necessitating contiguous involution with epinephrine, which is the sole medicine approved by the US regulator for specified emergencies.

In 2024, ALK-Abelló acquired the rights to neffy adrenaline nasal spray successful Europe and Canada, amongst different regions, from ARS for an upfront outgo of $145m.

"ARS Pharma’s epinephrine nasal spray 1mg present disposable successful US" was primitively created and published by Pharmaceutical Technology, a GlobalData owned brand.

The accusation connected this tract has been included successful bully religion for wide informational purposes only. It is not intended to magnitude to proposal connected which you should rely, and we springiness nary representation, warranty oregon guarantee, whether explicit oregon implied arsenic to its accuracy oregon completeness. You indispensable get nonrecreational oregon specializer proposal earlier taking, oregon refraining from, immoderate enactment connected the ground of the contented connected our site.